Note: Ingredients listed on restricted chemical lists
EC/CAS
203-872-2
Name of the chemical
Diethylene glycol (DEG); 2,2′-oxydiethanol for traces level, see Annex III
Concentration
30,00%-<50
General Information
Version
1.2
Revision date
2024-01-19
Product name
HYDROTHERM 42 HFC
1.2.2. Uses advised against
identified
Emergency telephone
+46 20 996 000
Icons in SDS
Company Information
company name
FUCHS LUBRICANTS SWEDEN AB
e-mail address of the competent person responsible for the Safety Data Sheet
fse-hseasc@fuchs.com
GHS Information
Signal word
Warning
Hazard Codes
Hazard statements (CLP)
H302, H315, H319
Hazard statements
Code
Statements
H302
Harmful if swallowed
Section 2
SECTION 2: Hazards identification
2.1 Classification of the substance or mixture
The product has been classified and labelled as hazardous according to regulation (EU)
Health hazards
Acute toxicity (Oral) Skin irritation Serious eye irritation Category 4 H302: Harmful if swallowed. Category 2 H315: Causes skin irritation. Category 2 H319: Causes serious eye irritation. Hazard summary
Physical hazards
No data available.
Signal word
Warning
Hazard statements
H302: Harmful if swallowed. H315: Causes skin irritation. H319: Causes serious eye irritation.
Prevention
P264: Wash skin thoroughly after handling. P270: Do not eat, drink or smoke when using this product. P280: Wear protective gloves/ eye protection/ face protection.
Response
P301+P312+P330 IF SWALLOWED Call a POISON CENTER or doctor/ physician if you feel unwell. Rinse mouth. P337+P313 If eye irritation persists Get medical advice/attention
Disposal
P501: Dispose of contents/ container to an approved waste disposal plant. 2.3 Information on other haz- ards By handling of mineral oil products and chemical products no particular hazard is known when normal precautions (item 7) and personal protective equipment (item 8) are kept. The product may not be released into the envi- ronment without control. Endocrine disrupting prop- erties The substance/mixture does not contain components considered to have endocrine disrupting properties according to REACH Article 57(f) or Com- mission Delegated regulation (EU) 2017/2100 or Commission Regulation (EU) 2018/605 at levels of 0.1% or higher.
